Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes.

about

Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes.

Item

http://www.wikidata.org/entity/Q47875932

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Central nervous system gadolin ...... or hereditary tumor syndromes.

@en

Central nervous system gadolin ...... or hereditary tumor syndromes.

@nl

type

Item

label

Central nervous system gadolin ...... or hereditary tumor syndromes.

@en

Central nervous system gadolin ...... or hereditary tumor syndromes.

@nl

prefLabel

Central nervous system gadolin ...... or hereditary tumor syndromes.

@en

Central nervous system gadolin ...... or hereditary tumor syndromes.

@nl

P1476

Central nervous system gadolin ...... for hereditary tumor syndromes

@en

P2093

Anne C Houtman

http://www.w3.org/2001/XMLSchema#string

Bieke Lefevere

http://www.w3.org/2001/XMLSchema#string

Dirk Michielsen

http://www.w3.org/2001/XMLSchema#string

Evelynn Vergauwen

http://www.w3.org/2001/XMLSchema#string

Michel Van Lint

http://www.w3.org/2001/XMLSchema#string

Peter Janssens

http://www.w3.org/2001/XMLSchema#string

Susanne Bohler

http://www.w3.org/2001/XMLSchema#string

Sven Gläsker

http://www.w3.org/2001/XMLSchema#string

Vera Van Velthoven

http://www.w3.org/2001/XMLSchema#string

P2860

von Hippel-Lindau disease

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration

MRI contrast agents: basic chemistry and safety.

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.

Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus.

T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration.

P2888

s13053-017-0084-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13053-017-0084-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100191741

http://www.w3.org/2001/XMLSchema#string

P698

29312473

http://www.w3.org/2001/XMLSchema#string

P932

5756358

http://www.w3.org/2001/XMLSchema#string